Marina Forte, NP
Nurse Practitioner · Sonoma, CANPI 1356013049
Payments from drug & device makers
Across 71 payments — averaging $26.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$400
- AbbVie$285
- Regeneron Healthcare Solutions, Inc.$207
- Sun Pharmaceutical Industries Inc.$188
- Lilly USA, LLC$147
- Amgen$132
- plus $513 from 9 others
What the payments were for
- Food & beverage$1,68790%
- Education$18410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 11 | $400 |
| AbbVie | 13 | $285 |
| Regeneron Healthcare Solutions, Inc. | 6 | $207 |
| Sun Pharmaceutical Industries Inc. | 7 | $188 |
| Lilly USA, LLC | 5 | $147 |
| Amgen | 6 | $132 |
| Incyte Corporation | 5 | $112 |
| Johnson & Johnson | 4 | $89 |
| Novartis | 3 | $80 |
| LEO Pharma Inc. | 3 | $80 |
| Galderma Laboratories, L.p. | 4 | $73 |
| Pfizer | 1 | $25 |
| UCB, Inc. | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| LNHC, Inc | 1 | $14 |
How this compares
$1,872 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 49 | $2,353 |
| Ketoconazole | 93 | $1,761 |
| Fluorouracil | 26 | $1,703 |
| Clobetasol Propionate | 24 | $1,594 |
| Tretinoin | 15 | $1,386 |
| Triamcinolone Acetonide | 84 | $1,088 |
| Metronidazole | 21 | $1,013 |
| Clindamycin Phosphate | 15 | $925 |
| Doxycycline Monohydrate | 53 | $826 |
| Mupirocin | 95 | $560 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $499 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 11 | $498 |
| Clotrimazole | 27 | $303 |
| ValacyclovirValacyclovir Hcl | 11 | $290 |
| Spironolactone | 23 | $229 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Sonoma
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.